| Authors: |
Butt H; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC., Sathish S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., London E; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Le A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Li Q; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Gudmundsdottir B; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Lee DY; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Burke EV; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Yates BP; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Liu DR; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA.; Howard Hughes Medical Institute, Harvard University, Cambridge, MA., Hsieh M; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN., Eaton WA; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Pierciey FJ Jr; Bluebird Bio, Inc, Somerville, MA., Newby GA; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD. |
